- Corporate Officers - G
- Gill David N
Insider Trading History of Gill David N
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gill David N since 2006.
This trader's CIK number is 1106519.
At the time of last reporting, Gill David N was the Director of Evolus, Inc.. (stock ticker symbol EOLS).
Also see all insider trading activities at Evolus, Inc..
Note that in the past
GILL DAVID N also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Evolus, Inc. (EOLS) by Gill David N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | EOLS | 0 | $0 | 10,361 | $131,010 | 0 | $0 |
| 2022 | EOLS | 0 | $0 | 10,313 | $137,664 | 0 | $0 |
| 2019 | EOLS | 2,000 | $27,300 | 0 | $0 | 0 | $0 |
| 2018 | EOLS | 3,000 | $38,301 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Lemaitre Vascular Inc (LMAT) by Gill David N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | LMAT | 2,000 | $12,296 | 0 | $0 | 0 | $0 |
| 2006 | LMAT | 2,000 | $12,100 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Y-mabs Therapeutics, Inc. (YMAB) by Gill David N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2021 | YMAB | 0 | $0 | 2,000 | $93,046 | 2,000 | $22,320 |
| 2020 | YMAB | 0 | $0 | 6,000 | $271,530 | 6,000 | $66,960 |
Yearly summary of insider trading at Endochoice Holdings, Inc. (GI) by Gill David N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2016 | GI | 7,000 | $33,249 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Melinta Therapeutics, Inc. /new/ (MLNT) by Gill David N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | MLNT | 5,000 | $30,450 | 0 | $0 | 0 | $0 |
| 2017 | MLNT | 5,000 | $14,720 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Ocugen, Inc. (HSGX) by Gill David N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | HSGX | 6,000 | $10,479 | 0 | $0 | 0 | $0 |
| 2016 | HSGX | 8,000 | $14,550 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Strongbridge Biopharma Plc (SBBP) by Gill David N
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2020 | SBBP | 8,000 | $17,040 | 0 | $0 | 0 | $0 |
Insider trading activities at 7 companies by Gill David N:
1. Evolus, Inc. (EOLS)
2. Lemaitre Vascular Inc (LMAT)
3. Y-mabs Therapeutics, Inc. (YMAB)
4. Endochoice Holdings, Inc. (GI)
5. Melinta Therapeutics, Inc. /new/ (MLNT)
6. Ocugen, Inc. (HSGX)
7. Strongbridge Biopharma Plc (SBBP)
Table 1. Insider trading of Evolus, Inc. (EOLS) by Gill David N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-05-14 | EOLS | Sale | 6,718 | 12.60 | 84,653 |
| 2024-05-13 | EOLS | Sale | 3,643 | 12.72 | 46,357 |
| 2022-05-13 | EOLS | Sale | 5,313 | 13.10 | 69,584 |
| 2022-05-16 | EOLS | Sale | 5,000 | 13.62 | 68,080 |
| 2019-06-13 | EOLS | Buy | 2,000 | 13.65 | 27,300 |
| 2018-12-14 | EOLS | Buy | 3,000 | 12.77 | 38,301 |
Table 2. Insider trading of Lemaitre Vascular Inc (LMAT) by Gill David N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-05-15 | LMAT | Buy | 200 | 6.03 | 1,206 |
| 2007-05-16 | LMAT | Buy | 800 | 6.05 | 4,840 |
| 2007-05-09 | LMAT | Buy | 1,000 | 6.25 | 6,250 |
| 2006-10-31 | LMAT | Buy | 2,000 | 6.05 | 12,100 |
Table 3. Insider trading of Y-mabs Therapeutics, Inc. (YMAB) by Gill David N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2021-01-19 | YMAB | Sale | 2,000 | 46.52 | 93,046 |
| 2021-01-19 | YMAB | Option Ex | 2,000 | 11.16 | 22,320 |
| 2020-11-18 | YMAB | Sale | 2,000 | 45.77 | 91,530 |
| 2020-11-18 | YMAB | Option Ex | 2,000 | 11.16 | 22,320 |
| 2020-11-03 | YMAB | Option Ex | 4,000 | 11.16 | 44,640 |
| 2020-11-03 | YMAB | Sale | 4,000 | 45.00 | 180,000 |
Table 4. Insider trading of Endochoice Holdings, Inc. (GI) by Gill David N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2016-03-10 | GI | Buy | 2,000 | 4.70 | 9,400 |
| 2016-03-07 | GI | Buy | 5,000 | 4.77 | 23,849 |
Table 5. Insider trading of Melinta Therapeutics, Inc. /new/ (MLNT) by Gill David N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-05-25 | MLNT | Buy | 5,000 | 6.09 | 30,450 |
| 2017-01-03 | CEMP | Buy | 5,000 | 2.94 | 14,720 |
Table 6. Insider trading of Ocugen, Inc. (HSGX) by Gill David N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-08-16 | HSGX | Buy | 3,000 | 1.81 | 5,439 |
| 2017-05-16 | HSGX | Buy | 3,000 | 1.68 | 5,040 |
| 2016-12-15 | HSGX | Buy | 3,000 | 1.65 | 4,950 |
| 2016-12-09 | HSGX | Buy | 5,000 | 1.92 | 9,600 |
Table 7. Insider trading of Strongbridge Biopharma Plc (SBBP) by Gill David N
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2020-09-24 | SBBP | Buy | 8,000 | 2.13 | 17,040 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Gill David N
(Director of Evolus, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.